Thyrocare launches blood-based cancer screening profile

Thyrocare Technologies is launching blood-based cancer screening profile consisting of Easycheck360, which is a cancer screening test profile for early detection of 16 types of cancers that is processed by Datar Cancer Genetics.

This screening test is processed by Datar Cancer Genetics (Datar) and Thyrocare’s popular wellness profile Aarogyam, which is available for Rs 8,999. Cancer screening through blood is a breakthrough patented technology and the research data has been published in various leading journals as well. Thyrocare’s Aarogyam which is a cost-effective package offers high quality investigations for many metabolic disorders. As per the arrangement between the two companies, Thyrocare and Datar, Easycheck360 is set to be made available exclusively through Thyrocare throughout the country during the time period of the contract.

Thyrocare Technologies Limited is a healthcare service provider. The company operates with a Centralised Processing Laboratory (CPL) in Mumbai for esoteric tests and regional processing laboratory in metro cities of India and other parts of Asia. It offers such technologies which include Chemiluminescence Immunoassay (CLIA), Enzyme Linked Immunosorbent Assay (ELISA), High Performance Liquid Chromatography (HPLC), Capillary Electrophoresis (CE), etc.

On Monday, the stock of the company closed at Rs 619.90, up by 1.62 per cent or Rs 9.90 per share. The 52-week high is Rs 689.45 and 52-week low is Rs 406.65 on BSE.